Clinical Trial

Safety of Perioperative Anticoagulation Management in People With Active Cancer Undergoing Cancer-Related Surgery or Procedures (ACE-HIGH Study)

Study acronym: ACE-HIGH
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to help find how safe current practices are when managing blood thinners in people with cancer who are having surgery or medical procedures. Investigators will also measure how often bleeding or clotting problems happen in this setting. The goal is to use this information to improve future care and reduce these risks for patients. This study will determine whether contemporary practices can be safely applied to cancer patients, and also evaluate the blood thinner level left over in patient's body at the time of surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-01-20.
Trial Details
NCT Number NCT07372716
Lead Sponsor Ottawa Hospital Research Institute
Conditions Thrombosis, Cancer, Thrombosis, Deep Vein, Atrial Fibrillation (AF), Venous Thromboembolic Event, Bleeding
Enrollment 700 participants
Start Date 2026-03
Primary Completion 2030-12 (estimated)
Study Completion 2031-12 (estimated)
Updated on ClinicalTrials.gov 2026-02-06